VoICE Immunization Evidence

Fulfilling the promise of rotavirus vaccines: how far have we come since licensure?

Authored by: Patel, M.M., Glass, R., Desai, R., Tate, J.E. & Parashar, U.D.

Appears in:

From the VoICE Editors

This data is from a review article of multiple studies that evaluated the benefits of rotavirus vaccine following vaccine introduction.

Key Idea

Rotavirus hospital admissions in unvaccinated children aged 2-5 yrs. of age, who where not age-eligible to receive the Rotavirus vaccine (RVV), were reduced by 41%-92% in the US, 30-70% in Australia, 20-64% in Belgium, 35% in Austria and 41-81% in El Salvador following the introduction of RVV. In addition, there was a reduction in hospitalizations due to gastroenteritis of any cause by 17-51% in the US and 40% in Australia.

Published In

Patel, M.M., Glass, R., Desai, R., Tate, J.E. & Parashar, U.D. 2012. Fulfilling the promise of rotavirus vaccines: how far have we come since licensure?. Lancet Infectious Diseases. 12(7).

Disease or Vaccine